---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-010175"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2024-03-18T23:59:59+00:00"
generated_at: "2026-06-04T15:06:35.152911+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# BioSig receives Nasdaq delisting notice for being a public shell; appeal hearing May 7

## Summary
- Nasdaq Staff determined BioSig is a 'public shell' with no operating business, citing recent workforce reduction (16 employees, exec resignations) and now one employee and one board member.
- Company also fails minimum $35M Market Value of Listed Securities requirement under Rule 5550(b)(2).
- BioSig had already failed minimum bid price rule and cannot get a second cure period due to insufficient stockholders' equity.
- Hearing before Nasdaq Hearings Panel scheduled for May 7, 2024; company intends to appeal the additional delisting basis.

## SEC filing metadata
- accession: 0001493152-24-010175
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2024-03-18T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000149315224010175/0001493152-24-010175-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000149315224010175/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-010175
- JSON: https://secwatch.observer/filing/0001493152-24-010175.json
- Plain text: https://secwatch.observer/filing/0001493152-24-010175.txt

## Key facts
- Listing & Compliance Notices
  Streamex Corp. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)(2)
  source text: March 5, 2024, BioSig Technologies, Inc. (the “Company”) received a letter from the Listing Qualifications Department of Nasdaq (the “Staff”) stating that the Company has not regained compliance with Listing Rule 5550(a)(2) because the Company’s common stock did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market, and the Company is not eligible for a second 180 day cure period under Rule 5810(c)(3)(A)(2) because the Company does not comply with the $5,000,000 minimum stockholders’ equity initial listing requirement for The Nasdaq Capit
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000149315224010175/0001493152-24-010175-index.htm
- Listing & Compliance Notices
  Streamex Corp. received a nasdaq delisting notice notice regarding board independence (rules 5101, 5605).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: board independence
  - Rules: 5101, 5605
  source text: March 12, 2024, the Company received a letter from the Staff stating that based upon the Staff’s review of the Company and pursuant to Listing Rule 5101, the Staff believes that the Company no longer has an operating business and is a “public shell,” and that the continued listing of its securities is no longer warranted, in view of the following: ● On February 5, 2024, the Company disclosed in a Form 8-K that the Company commenced a workforce reduction consisting of 16 employees including the Chief Operating Officer and the Chief Commercial Officer; ● On February 21, 2024, the Company disc
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000149315224010175/0001493152-24-010175-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.